VolitionRx Limited Other Current Assets
VolitionRx Limited (VNRX) had Other Current Assets of $335.59 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $335.59K.
- 2026-03-31: Other Assets, Current $291.19K.
- 2025-12-31: Other Assets, Current $192.41K.
- 2025-09-30: Other Assets, Current $363.51K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $335.59K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $291.19K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $192.41K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $363.51K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $343.25K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $255.77K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $343.14K 10-K · filed 2026-03-31 |
| 2024-09-30 | $384.19K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $350.93K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $470.10K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $360.13K 10-K · filed 2025-03-31 |
| 2023-09-30 | $493.35K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $542.64K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $716.91K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $447.57K 10-K · filed 2024-03-25 |
| 2022-09-30 | $426.23K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $973.98K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $888.83K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $786.64K 10-K · filed 2023-03-15 |
| 2021-09-30 | $598.44K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $527.83K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $496.90K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $576.66K 10-K · filed 2022-03-30 |
| 2020-09-30 | $791.35K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $525.01K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $377.78K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $322.59K 10-K · filed 2021-03-22 |
| 2019-09-30 | $184.86K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $193.12K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $247.50K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $229.75K 10-K · filed 2020-02-20 |
| 2018-09-30 | $229.78K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $200.63K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $203.93K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $202.29K 10-K · filed 2019-03-13 |
| 2017-09-30 | $170.88K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $146.98K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $169.08K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $166.89K 10-K · filed 2018-03-01 |
| 2016-09-30 | $191.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $221.63K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $164.31K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $153.72K 10-K · filed 2017-03-10 |
| 2015-09-30 | $151.65K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $118.73K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $67.32K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $52.66K 10-K · filed 2016-03-11 |
| 2014-09-30 | $117.41K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $73.08K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $46.98K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $34.61K 10-K · filed 2015-03-18 |
| 2013-09-30 | $32.77K 10-Q · filed 2013-10-31 |
| 2013-06-30 | $39.67K 10-Q · filed 2013-07-29 |
| 2013-03-31 | $33.22K 10-Q · filed 2013-05-06 |
| 2012-12-31 | $39.37K 10-K · filed 2014-03-28 |
| 2012-09-30 | $40.19K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $34.68K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $34.33K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $30.75K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |